Chi Xiangyang, Xia Lingyun, Zhang Guanying, Chi Ximin, Huang Bangdong, Zhang Yuanyuan, Chen Zhengshan, Han Jin, Wu Liushu, Li Zeya, Sun Hancong, Huang Ping, Yu Changming, Chen Wei, Zhou Qiang
Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, China.
Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, Institute of Biology, Westlake Institute for Advanced Study, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.
Cell Discov. 2023 Apr 4;9(1):37. doi: 10.1038/s41421-023-00535-1.
The pandemic of COVID-19 caused by SARS-CoV-2 continues to spread around the world. Mutant strains of SARS-CoV-2 are constantly emerging. At present, Omicron variants have become mainstream. In this work, we carried out a systematic and comprehensive analysis of the reported spike protein antibodies, counting the epitopes and genotypes of these antibodies. We further comprehensively analyzed the impact of Omicron mutations on antibody epitopes and classified these antibodies according to their binding patterns. We found that the epitopes of the H-RBD class antibodies were significantly less affected by Omicron mutations than other classes. Binding and virus neutralization experiments showed that such antibodies could effectively inhibit the immune escape of Omicron. Cryo-EM results showed that this class of antibodies utilized a conserved mechanism to neutralize SARS-CoV-2. Our results greatly help us deeply understand the impact of Omicron mutations. Meanwhile, it also provides guidance and insights for developing Omicron antibodies and vaccines.
由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的新型冠状病毒肺炎(COVID-19)大流行仍在全球蔓延。SARS-CoV-2的突变株不断出现。目前,奥密克戎变种已成为主流。在这项工作中,我们对已报道的刺突蛋白抗体进行了系统全面的分析,统计了这些抗体的表位和基因型。我们进一步全面分析了奥密克戎突变对抗体表位的影响,并根据它们的结合模式对这些抗体进行了分类。我们发现,与其他类别相比,H-RBD类抗体的表位受奥密克戎突变的影响明显较小。结合和病毒中和实验表明,这类抗体能够有效抑制奥密克戎的免疫逃逸。冷冻电镜结果表明,这类抗体利用一种保守机制中和SARS-CoV-2。我们的结果极大地帮助我们深入了解奥密克戎突变的影响。同时,它也为开发针对奥密克戎的抗体和疫苗提供了指导和见解。